Success Story: NIW Approved with Premium Processing for a Diagnostic Pathology Physician Advancing AI-Based Cancer Monitoring
Client’s Testimonial:
"Chen Immigration attorneys and their paralegal team are very professional and efficient. They are prompt in communication. I never hesitated to ask them questions, and they always encouraged me to gather more evidence and never hesitated to edit the petition letter. I would like to mention they work on the case with full attention to detail.”
On March 31st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Training Physician in the Field of Diagnostic Pathology (Approval Notice).
General Field: Diagnostic Pathology
Position at the Time of Case Filing: Training Physician
Approval Notice Date: March 31st, 2026
Processing Time: 1 month, 11 days (Premium Processing Requested)
Case Summary:
Client Background and Proposed Endeavor
The client holds an M.B.B.S. and works in diagnostic pathology in the United States as a training physician in an academic clinical setting. As an expert in the field, the client’s proposed endeavor is to continue developing and applying artificial intelligence-based diagnostic models, digital pathology workflows, and evidence-based quality-improvement frameworks. These efforts aim to improve the detection of minimal residual disease in cancer, reduce diagnostic variability, and expand access to high-quality pathology services while strengthening national disease surveillance and public health decision-making.
National Significance of the Research
In the petition, we framed the endeavor as an area of clear, substantial merit and national importance because high-quality, consistent diagnostics directly influence treatment decisions, recurrence monitoring, and patient safety. We emphasized that AI-enabled workflows and standardized quality-improvement frameworks can help reduce avoidable laboratory and interpretation errors, improve consistency across healthcare settings, and support earlier, more cost-effective clinical decision-making. We also positioned the client’s work as scalable, meaning the benefits can extend beyond a single hospital or lab and support broader public health and surveillance needs.
Impressive Credentials and Achievements
To show the client is well-positioned to advance the endeavor, we presented objective indicators of productivity, independent reliance, and peer trust, while explaining how an adjudicator could reasonably interpret these metrics rather than treating them as self-evidently sufficient. At the time of filing, the client had authored 11 peer-reviewed journal articles, including 3 first-authored publications, and 12 abstracts, including 2 first-authored abstracts. The client’s work had been cited 51 times. We also highlighted that two publications ranked among the top 10% most cited in their field for their publication years, which helped contextualize impact in a way that accounts for different citation climates and timelines. Separately, the client completed at least 14 peer reviews, which we positioned as a trust signal because review invitations typically go to researchers recognized for expertise and sound judgment.
NIW Approval and Outlook
USCIS approved the client’s NIW petition filed with Premium Processing. This outcome reflects a cohesive presentation linking the researcher's clinical expertise to documented independent reliance through citations and sustained peer trust through peer-review service. By anchoring the petition in both technical AI innovation and clinical safety, we secured a decisive victory for this diagnostic specialist.